FI84606B - Ettstegsfoerfarande foer framstaellning av blandsubstituerade 1,2-diacyl-sn-glycero-3-fosfokoliner. - Google Patents
Ettstegsfoerfarande foer framstaellning av blandsubstituerade 1,2-diacyl-sn-glycero-3-fosfokoliner. Download PDFInfo
- Publication number
- FI84606B FI84606B FI874956A FI874956A FI84606B FI 84606 B FI84606 B FI 84606B FI 874956 A FI874956 A FI 874956A FI 874956 A FI874956 A FI 874956A FI 84606 B FI84606 B FI 84606B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- mmol
- glycero
- phosphocholine
- reaction
- Prior art date
Links
- 239000000126 substance Substances 0.000 title description 9
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 8
- 239000002841 Lewis acid Substances 0.000 claims abstract description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 7
- 150000007517 lewis acids Chemical class 0.000 claims abstract description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 6
- 239000011541 reaction mixture Substances 0.000 claims abstract description 6
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 5
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 66
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 29
- 238000006243 chemical reaction Methods 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical group OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 6
- 125000005586 carbonic acid group Chemical group 0.000 claims description 5
- 125000003107 substituted aryl group Chemical group 0.000 claims description 5
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 4
- 150000008064 anhydrides Chemical class 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 239000011877 solvent mixture Substances 0.000 claims description 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 239000011592 zinc chloride Substances 0.000 claims description 3
- 235000005074 zinc chloride Nutrition 0.000 claims description 3
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 2
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 claims description 2
- 230000003197 catalytic effect Effects 0.000 claims 1
- 238000010915 one-step procedure Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 101
- 239000000047 product Substances 0.000 description 55
- 235000011187 glycerol Nutrition 0.000 description 27
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 22
- 229960001231 choline Drugs 0.000 description 22
- 238000005481 NMR spectroscopy Methods 0.000 description 21
- 238000000921 elemental analysis Methods 0.000 description 20
- NGEZPLCPKXKLQQ-VOTSOKGWSA-N (e)-4-(3-methoxyphenyl)but-3-en-2-one Chemical compound COC1=CC=CC(\C=C\C(C)=O)=C1 NGEZPLCPKXKLQQ-VOTSOKGWSA-N 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 150000001336 alkenes Chemical class 0.000 description 7
- -1 methoxy, ethoxy, propyloxy, butyloxy Chemical group 0.000 description 7
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 6
- YBDWGEQMGDODTM-AREDZEPOSA-N [(2r)-2-[(z)-octadec-9-enoyl]oxy-3-trityloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C)C1=CC=CC=C1 YBDWGEQMGDODTM-AREDZEPOSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- NVKIIOSRYDXTMJ-UHFFFAOYSA-N 1-(1,2,4-triazol-1-yl)hexadecan-1-one Chemical compound CCCCCCCCCCCCCCCC(=O)N1C=NC=N1 NVKIIOSRYDXTMJ-UHFFFAOYSA-N 0.000 description 4
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- WVJVHUWVQNLPCR-UHFFFAOYSA-N octadecanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCC WVJVHUWVQNLPCR-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RLFNHLYUMLSMPB-UHFFFAOYSA-N (2,2,2-trifluoroacetyl) hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(=O)C(F)(F)F RLFNHLYUMLSMPB-UHFFFAOYSA-N 0.000 description 2
- CFGDUGSIBUXRMR-UHFFFAOYSA-N 1,2-dihydropyrrol-2-ide Chemical class C=1C=[C-]NC=1 CFGDUGSIBUXRMR-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XPSKGSAODDANJP-BOCKPCKKSA-N CCCCCCCC/C(\C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)=C\CCCCCCCC(O[C@H](CO)COP([O-])(OCC[N+](C)(C)C)=O)=O Chemical compound CCCCCCCC/C(\C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)=C\CCCCCCCC(O[C@H](CO)COP([O-])(OCC[N+](C)(C)C)=O)=O XPSKGSAODDANJP-BOCKPCKKSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- OCNZHGHKKQOQCZ-CLFAGFIQSA-N [(z)-octadec-9-enoyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OCNZHGHKKQOQCZ-CLFAGFIQSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- QPLGXKYZHULRBG-UHFFFAOYSA-N ethoxycarbonyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(=O)OCC QPLGXKYZHULRBG-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000010490 three component reaction Methods 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- UGFFWUOTERPPQC-UHFFFAOYSA-N (4,4,4-trifluoro-3-methylbutanoyl) 4,4,4-trifluoro-3-methylbutanoate Chemical compound FC(F)(F)C(C)CC(=O)OC(=O)CC(C)C(F)(F)F UGFFWUOTERPPQC-UHFFFAOYSA-N 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AWFIQQPKTAGLLF-UHFFFAOYSA-N 1-(1,2,4-triazol-1-yl)octadecan-1-one Chemical compound CCCCCCCCCCCCCCCCCC(=O)N1C=NC=N1 AWFIQQPKTAGLLF-UHFFFAOYSA-N 0.000 description 1
- PLOBETYBHVQUTP-UHFFFAOYSA-N 1-(tetrazol-1-yl)hexadecan-1-one Chemical compound CCCCCCCCCCCCCCCC(=O)N1C=NN=N1 PLOBETYBHVQUTP-UHFFFAOYSA-N 0.000 description 1
- FWMYJLDHIVCJCT-ZTIMHPMXSA-N 1-[(9Z,12Z)-octadecadienoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC\C=C/C\C=C/CCCCC FWMYJLDHIVCJCT-ZTIMHPMXSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- XPAXRSJGGFVTFM-RUZDIDTESA-N 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C XPAXRSJGGFVTFM-RUZDIDTESA-N 0.000 description 1
- FFLOXQLYEUNLJS-AREMUKBSSA-N 1-palmitoyl-2-butanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCC)COP([O-])(=O)OCC[N+](C)(C)C FFLOXQLYEUNLJS-AREMUKBSSA-N 0.000 description 1
- PSVRFUPOQYJOOZ-QNPWAGBNSA-N 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC PSVRFUPOQYJOOZ-QNPWAGBNSA-N 0.000 description 1
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- TVPCUVQDVRZTAL-UHFFFAOYSA-N 2-ethylhexanoyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OC(=O)C(CC)CCCC TVPCUVQDVRZTAL-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- NEGQHKSYEYVFTD-HSZRJFAPSA-N 2-palmitoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](CO)COP([O-])(=O)OCC[N+](C)(C)C NEGQHKSYEYVFTD-HSZRJFAPSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- NPDACUSDTOMAMK-UHFFFAOYSA-N 4-Chlorotoluene Chemical compound CC1=CC=C(Cl)C=C1 NPDACUSDTOMAMK-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QBEIAYOWNFAPEA-UHFFFAOYSA-N 9,10-dibromooctadecanoyl 9,10-dibromooctadecanoate Chemical compound CCCCCCCCC(Br)C(Br)CCCCCCCC(=O)OC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC QBEIAYOWNFAPEA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- ZILMQYHJIVAEHG-CBMSSGECSA-N CCCCC/C=C\C/C=C\C(C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)/C=C\C/C=C\CCCC(O[C@H](CO)COP([O-])(OCC[N+](C)(C)C)=O)=O Chemical compound CCCCC/C=C\C/C=C\C(C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)/C=C\C/C=C\CCCC(O[C@H](CO)COP([O-])(OCC[N+](C)(C)C)=O)=O ZILMQYHJIVAEHG-CBMSSGECSA-N 0.000 description 1
- DYFLMOMVTFTUMP-HLXFJAIWSA-N CCCCCCCCC(C(CCCCCCCC(=O)O[C@@H](CO)COC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)Br)Br Chemical compound CCCCCCCCC(C(CCCCCCCC(=O)O[C@@H](CO)COC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)Br)Br DYFLMOMVTFTUMP-HLXFJAIWSA-N 0.000 description 1
- HEYUKFKUHBWZJR-BDCODIICSA-N CCCCCCCCCCCCCCCC(O[C@H](COC(C(CC)CCCC)=O)COP([O-])(OCC[N+](C)(C)C)=O)=O Chemical compound CCCCCCCCCCCCCCCC(O[C@H](COC(C(CC)CCCC)=O)COP([O-])(OCC[N+](C)(C)C)=O)=O HEYUKFKUHBWZJR-BDCODIICSA-N 0.000 description 1
- KNALEYNOBDKJMV-HHHXNRCGSA-N CCCCCCCCCCCCCCCC(O[C@H](COCCCC)COP([O-])(OCC[N+](C)(C)C)=O)=O Chemical compound CCCCCCCCCCCCCCCC(O[C@H](COCCCC)COP([O-])(OCC[N+](C)(C)C)=O)=O KNALEYNOBDKJMV-HHHXNRCGSA-N 0.000 description 1
- NNGCJBLNKIXELR-WJOKGBTCSA-N CCCCCCCCCCCCCCCCCCCCCCCC(O[C@H](CO)COP([O-])(OCC[N+](C)(C)C)=O)=O Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O[C@H](CO)COP([O-])(OCC[N+](C)(C)C)=O)=O NNGCJBLNKIXELR-WJOKGBTCSA-N 0.000 description 1
- CIPJJENQWGKBFD-SCBLGKRXSA-N C[N+](C)(C)CC(C(COC)=O)OP([O-])(OC[C@@H](COC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)O)=O Chemical compound C[N+](C)(C)CC(C(COC)=O)OP([O-])(OC[C@@H](COC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)O)=O CIPJJENQWGKBFD-SCBLGKRXSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- KDXVSDQFHRZPKV-RUZDIDTESA-N PC(2:0/16:0) Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](COC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C KDXVSDQFHRZPKV-RUZDIDTESA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PSJLLBQQNYHNHN-CUNZZOHOSA-N [(2R)-2-(2-ethylhexanoyloxy)-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)C(CC)CCCC)COP([O-])(=O)OCC[N+](C)(C)C PSJLLBQQNYHNHN-CUNZZOHOSA-N 0.000 description 1
- IEHJHFUNQGCGOK-FYEOKJGGSA-N [(2R)-2-(2-ethylhexanoyloxy)-3-trityloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OC[C@@H](OC(=O)C(CC)CCCC)COP([O-])(=O)OCC[N+](C)(C)C)C1=CC=CC=C1 IEHJHFUNQGCGOK-FYEOKJGGSA-N 0.000 description 1
- QMQDEALCUWHAJU-GDLZYMKVSA-N [(2R)-2-(2-methylpropanoyloxy)-3-trityloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OC[C@@H](OC(=O)C(C)C)COP([O-])(=O)OCC[N+](C)(C)C)C1=CC=CC=C1 QMQDEALCUWHAJU-GDLZYMKVSA-N 0.000 description 1
- AZGVUJNTJSDJRE-QQCYDSABSA-N [(2R)-2-(9,10-dibromooctadecanoyloxy)-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC AZGVUJNTJSDJRE-QQCYDSABSA-N 0.000 description 1
- STVKTDZXVYGXBR-FXDYGKIASA-N [(2R)-2-hexadecanoyloxy-3-(4,4,4-trifluoro-3-methylbutanoyl)oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CC(C)C(F)(F)F)COP([O-])(=O)OCC[N+](C)(C)C STVKTDZXVYGXBR-FXDYGKIASA-N 0.000 description 1
- DPLPPXVAXBNBHB-FXDYGKIASA-N [(2R)-3-hexadecanoyloxy-2-(4,4,4-trifluoro-3-methylbutanoyl)oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CC(C)C(F)(F)F)COP([O-])(=O)OCC[N+](C)(C)C DPLPPXVAXBNBHB-FXDYGKIASA-N 0.000 description 1
- BDTYMGCNULYACO-MAZCIEHSSA-N [(9z,12z)-octadeca-9,12-dienoyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC BDTYMGCNULYACO-MAZCIEHSSA-N 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- OKZIUSOJQLYFSE-UHFFFAOYSA-N difluoroboron Chemical compound F[B]F OKZIUSOJQLYFSE-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000003135 glycerophosphocholine group Chemical group 0.000 description 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-O glycerylphosphorylcholine Chemical compound C[N+](C)(C)CCO[P@](O)(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-O 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- INEZDSXEWHMKOD-UHFFFAOYSA-N tetracosanoyl tetracosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC INEZDSXEWHMKOD-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
Claims (10)
1. Ettstegsförfarande för framställning av blandsubsti-tuerade enantiomerrena 1.2-diacyl-sn-glycero-3-fosfokoliner 5 med den formeln I O H2C - O - S - Rx (I)
10. J R, - C - O - CH
10- CH3 1 +l - O - P - O - CH, - CH, - N - CH, » L o ch3 där
20 R^ och R2 är oi ikä och är oberoende av varandra en even- tuellt substituerad Cj - C24_alkyl- eller C3 - C24~alkenyl-grupp, kännetecknat därav, att 1-O-trifenyl-metyl-2-acyl-ns-qlycero-3-fosfokolin med formeln II
25 H2C - O - T (II) O II R2 - c - O - CH I o- ch, 50 li +i H,C - O - P - O - CH, - CH, - N - CH, Il i o ch3 35 där R2 avser samma som i formeln I, och T är en eventuellt substituerad trifenylmetylgrupp, bringas att reagera med ett reaktivt karboxylsyraderivat med formeln III 40 Rx - CO - X (III) 32 84606 där Rl avser samma som i formeln I och X är a) en karboxylsyragrupp med formeln R^-CO-C)- (IV) eller
2. Förfarande enligt patentkrav 1, kännetecknat därav, att reaktionen utföres i metylenklorid, kloroform, 25 dietyleter, acetonitril eller etylacetat.
3. Förfarande enligt nägot av patentkraven 1 eller 2, kännetecknat därav, att en förening med formeln II bringas att reagera med anhydrid med formeln III, där X 30 är en karboxylsyragrupp med formeln IV, eller med en bland-anhydrid med formeln III, där X är en trifluoracetatgrupp med formeln V.
4. Förfarande enligt nägot av patentkraven 1 eller 2, 35 kännetecknat därav, att en förening med formeln II bringas att reagera med 1-acyl-1,2,4-triazol med formeln III eller med N-acyl-tetrazol, varvid acyl avser en grupp R^-CO-, där Ri avser samma som i patentkrav 1. 40 5. Förfarande enligt patentkrav 1 eller 2, k ä n n e - 33 84606 t e c k n a t därav, att förening med formeln II bringas att reagera med en aktiv ester med formeln Hi, där X är en koisyragrupp med formeln VI eller en sulfonsyragrupp med formeln VII, och i dessa grupper R3 är metyl, etyl, bensyl 5 eller fenyl och R4 är metyl, etyl eller trifluormetyl.
5 CF3-CO-O- (V), varvid R^ i formeln (IV) avser samma som i formeln (I), b) en kolsyragrupp med formeln R3-O-CO-O- (VI) varvid R3 är lägre alkyl, aralkyl, eller eventuellt substituerad aryi, c) en sulfonsyragrupp med formeln R4-SO2-O- (VII) varvid R4 10 är lägre alkyl, perfluorerad lägre alkyl eller eventuellt substituerad aryl, eller d) en eventuellt kondenserad femmedlems heterocsyklisk grupp med minst tvä N-atomer i ringen, i närvaro av oorganisk eller organisk protonsyra, Lewis-15 syra eller addukter, som bildats med dessad elektrongiväre i ett förhällande till reaktionskomponenter inert lösnings-medel eller 1ösningsmedelsblandning vid temperaturer mellan -lOoC - och lösningsmedlets eller den lägst kokande lös-ningskomponentens kokpunkt och de härvid erhällna förenin-20 garna med den ailmännaformeln I isoleras frän reaktions-blandningen.
6. Förfarande enligt nägot av patentkraven 1-5, k ä n -netecknat därav, att reaktionen utföres i närvaro av torr, gasformig saltsyra, trifluorättiksyra eller metan- 10 sulfonsyra.
7. Förfarande enligt nägot av patentkraven 1-5, k ä n -netecknat därav, att reaktionen utföres i närvaro av Lewis-syra, företrädesvis bortrifluorid, bortriklorid, 15 aluminiumtriklorid eller zinkklorid.
8. Förfarande enligt patentkrav 7, kännetecknat därav, att reaktionen utföres i närvaro av bortrifluorid- ’ eterat. 20
9. Förfarande enligt nägot av patentkraven 1-10, kännetecknat därav, att ett acyleringsmedel med formeln II användes i ett 1,2 - 2 faldigt molöverskott och en katalytsyra i ett 2-8 faldigt molöverskott beräknat pä 25 utgängsföreningen med formeln III.
10. Förfarande enligt nägot av patentkraven 1-9, kännetecknat därav, att reaktionen utföres vid tempe-raturer mellan 0o - 25oC. 30
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863638687 DE3638687A1 (de) | 1986-11-13 | 1986-11-13 | Einstufiges verfahren zur herstellung von gemischt substituierten 1,2-di-acyl-sn-glycero-3-phosphocholinen |
| DE3638687 | 1986-11-13 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI874956A0 FI874956A0 (fi) | 1987-11-10 |
| FI874956A FI874956A (fi) | 1988-05-14 |
| FI84606B true FI84606B (fi) | 1991-09-13 |
| FI84606C FI84606C (sv) | 1991-12-27 |
Family
ID=6313815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI874956A FI84606C (sv) | 1986-11-13 | 1987-11-10 | Ettstegsförfarande för framställning av blandsubstituerade 1,2-diacyl- sn-glycero-3-fosfokoliner |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4814112A (sv) |
| EP (1) | EP0267565B1 (sv) |
| JP (1) | JPS63139188A (sv) |
| AT (1) | ATE60058T1 (sv) |
| CA (1) | CA1300637C (sv) |
| DE (2) | DE3638687A1 (sv) |
| DK (1) | DK592787A (sv) |
| ES (1) | ES2019615B3 (sv) |
| FI (1) | FI84606C (sv) |
| GR (1) | GR3001330T3 (sv) |
| HU (1) | HU201558B (sv) |
| NO (1) | NO169009C (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2636896B2 (ja) * | 1988-08-24 | 1997-07-30 | キユーピー株式会社 | リン脂質系乳化剤 |
| US6602861B1 (en) * | 1992-04-16 | 2003-08-05 | Research Corporation Technologies, Inc. | Acylated phospholipid drugs |
| US5846516A (en) * | 1992-06-03 | 1998-12-08 | Alliance Pharmaceutial Corp. | Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications |
| US5698537A (en) * | 1996-06-18 | 1997-12-16 | Clarion Pharmaceuticals Inc. | Method of lowering the viscosity of mucus |
| JPWO2014112280A1 (ja) * | 2013-01-17 | 2017-01-19 | 学校法人日本大学 | 油性組成物及び増粘又はゲル形成剤 |
| KR20210005190A (ko) * | 2018-04-27 | 2021-01-13 | 가부시키가이샤 레오로지 키노쇼쿠힝겐큐죠 | 신규 플라스말로젠 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3577446A (en) * | 1968-09-09 | 1971-05-04 | American Home Prod | Phosphatidylalkanolamine derivatives |
| AT383130B (de) * | 1984-05-15 | 1987-05-25 | Chemie Linz Ag | Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin |
| US4710579A (en) * | 1984-11-09 | 1987-12-01 | Takeda Chemical Industries, Ltd. | 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof |
-
1986
- 1986-11-13 DE DE19863638687 patent/DE3638687A1/de not_active Withdrawn
-
1987
- 1987-10-30 CA CA000550848A patent/CA1300637C/en not_active Expired - Fee Related
- 1987-11-09 DE DE8787116516T patent/DE3767446D1/de not_active Expired - Fee Related
- 1987-11-09 NO NO874657A patent/NO169009C/no unknown
- 1987-11-09 EP EP87116516A patent/EP0267565B1/de not_active Expired - Lifetime
- 1987-11-09 ES ES87116516T patent/ES2019615B3/es not_active Expired - Lifetime
- 1987-11-09 AT AT87116516T patent/ATE60058T1/de not_active IP Right Cessation
- 1987-11-10 FI FI874956A patent/FI84606C/sv not_active IP Right Cessation
- 1987-11-10 US US07/119,366 patent/US4814112A/en not_active Expired - Fee Related
- 1987-11-12 HU HU875046A patent/HU201558B/hu not_active IP Right Cessation
- 1987-11-12 DK DK592787A patent/DK592787A/da not_active Application Discontinuation
- 1987-11-13 JP JP62285692A patent/JPS63139188A/ja active Pending
-
1991
- 1991-01-17 GR GR90400711T patent/GR3001330T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO169009B (no) | 1992-01-20 |
| HUT48262A (en) | 1989-05-29 |
| ATE60058T1 (de) | 1991-02-15 |
| JPS63139188A (ja) | 1988-06-10 |
| NO169009C (no) | 1992-04-29 |
| DE3767446D1 (de) | 1991-02-21 |
| EP0267565B1 (de) | 1991-01-16 |
| US4814112A (en) | 1989-03-21 |
| DK592787A (da) | 1988-05-14 |
| NO874657D0 (no) | 1987-11-09 |
| GR3001330T3 (en) | 1992-08-31 |
| FI874956A0 (fi) | 1987-11-10 |
| DK592787D0 (da) | 1987-11-12 |
| EP0267565A1 (de) | 1988-05-18 |
| NO874657L (no) | 1988-05-16 |
| FI874956A (fi) | 1988-05-14 |
| FI84606C (sv) | 1991-12-27 |
| ES2019615B3 (es) | 1991-07-01 |
| CA1300637C (en) | 1992-05-12 |
| DE3638687A1 (de) | 1988-05-19 |
| HU201558B (en) | 1990-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI60194C (fi) | Foerfarande foer framstaellning av bensil-monoketaler | |
| KR100442717B1 (ko) | 세프디니르의 결정성 아민 염 | |
| FI66847B (fi) | Foerfarande foer framstaellning av 4-hydroxi-2-oxo-pyrrolidinalkanamider | |
| KR20200090975A (ko) | 항-바이러스 뉴클레오티드 유사체의 제조 방법 | |
| FI77663C (sv) | Derivat av glycerofosfokolin och glyserofosfoetanolamin, deras framstä llning och användning. | |
| FI60867C (fi) | Foerfarande foer framstaellning av en terapeutiskt anvaendbar 7-d-(-)-alfa-amino-alfa-(p-acyloxifenylacetamido)-cefalosporansyra | |
| FI84606B (fi) | Ettstegsfoerfarande foer framstaellning av blandsubstituerade 1,2-diacyl-sn-glycero-3-fosfokoliner. | |
| Chandrakumar et al. | Syntheses of enzyme-inhibitory phospholipid analogs. Stereospecific synthesis of 2-amidophosphatidylcholines and related derivatives | |
| RU2045530C1 (ru) | (+)форма 7,8-дигидро-6,6- диметил-7- окси-8-амино -6н-пирано(2,3-f) бенз-2,1,3 -оксадиазола, показывающая правое вращение в этаноле | |
| BE550319A (sv) | ||
| FI75156C (sv) | Förfarande för framställning av nya 2,3,4-trinor-m-inter-fenylen-prost a-cyklinderivat med blodplatteaggregationshämmande effekt. | |
| KR0163599B1 (ko) | 2-알킬티오-1,3,4-티아디아졸의 제조방법 | |
| CN110950836B (zh) | 一种苯并二硫杂环戊烯类骨架化合物的制备方法 | |
| Kamijo et al. | 1-acyl-3-substituted imidazolium salts as highly reactive acylating agents | |
| FI70020B (fi) | Som mellanprodukter vid framstaellning av 15-hydroxi-imino-e-homoeburnanderivat anvaendbara 15-halogen-e-homoeburnanderivat foerfarande foer deras framstaellning och deras anvaendning | |
| FI91253C (sv) | Förfarande för framställning av 4-acyloxi-2-azetidinonderivat | |
| EP0230127A1 (en) | Synthesis of nizatidine | |
| US4423225A (en) | Process for the preparation of pyrazole | |
| US5391726A (en) | Preparation of giant ring compounds | |
| KR0159760B1 (ko) | 아실화 방법 | |
| US4091029A (en) | N-pentafluoropropionyl and n-heptafluorobutyryl proline | |
| AT388165B (de) | Einstufiges verfahren zur herstellung von gemischt substituierten 1,2-di-acyl-sn-glycero-3- phosphocholinen | |
| FI93730C (sv) | Förfarande för framställning av benso(kalkogeno)/4,3,2-cd/indazoler | |
| FI77843B (fi) | Foerfarande foer aendring av konfigurationen av optiskt aktiv 1-(2-cyklopentylfenoxi)-3-tert-butylamino-2-propanol och vid foerfarandet som mellanprodukt anvaend 1-tert-butylamino-4- (2-cyklopentylfenoximetyl)oxazoliniumhalogenid. | |
| JPS59181260A (ja) | 光学活性なイミダゾ−ル誘導体の製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: HAFSLUND NYCOMED PHARMA |